Clinical Trials Sponsored by Verity Pharmaceuticals Inc.

Total 4992 results

Verity Pharmaceuticals Inc.

Not yet recruiting

Evaluating Safety and Efficacy of Verity-BCG in BCG-naïve Patients With Intermediate and High-risk Non-muscle Invasive Bladder (NMIBC) (EVER)

Bladder Cancer | Urothelial Carcinoma Bladder | Bladder Cancer Recurrent | Neoplasm Recurrence | Urothelial Carcinoma Recurrent | Non-Invasive Bladder Urothelial Carcinoma
Verium Diagnostics, Inc.

Terminated

Study of Low Back Pain Using CERSR® Imaging Technology

Low Back Pain

United States
Verium Diagnostics, Inc.

Terminated

Post Market Study of the Electrophysiological Course of Low Back Pain Using CERSR Technology

Low Back Pain

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-514 in Patients With Chronic Hepatitis B Virus Infection Who Are Not Currently on Treatment

Chronic HBV Infection

Hong Kong, Taiwan
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects

RSV Infection

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)

Chronic HBV Infection

United States, Canada
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP-938 in Healthy Subjects

RSV Infection

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

A Study of EDP 305 in Healthy Subjects and Subjects With Presumptive NAFLD

Presumptive NAFLD

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects

RSV Infection

United States
Alexza Pharmaceuticals, Inc.
Pharmaceutical Research Associates

Unknown

Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder

Agitation,Psychomotor

United States
Enanta Pharmaceuticals, Inc
Pharmaceutical Research Associates

Completed

Drug-Drug Interaction Study Between EDP-938, Cyclosporine and Prednisone in Healthy Adult Subjects

RSV Infection

United States
Merit Medical Systems, Inc.

Not yet recruiting

Bearing nsPVA Embolization for Uterine Artery Embolization

Uterine Fibroid
Merit Medical Systems, Inc.

Recruiting

Streamlined Localization Using SCOUT® at Biopsy (STREAMLoc )

Breast Cancer

Canada
Merit Medical Systems, Inc.

Completed

Surfacer System to Facilitate Access in Venous Occlusions (SAVE)

Chronic Venous Thrombosis | Venous Thrombosis Upper Extremity | Venous Thrombosis Upper Extremity Superficial Veins

Austria, Germany, Italy
Merit Medical Systems, Inc.

Completed

Embosphere® PROstate Post Market Study (PROstate)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

United States, United Kingdom, Italy, France
Merit Medical Systems, Inc.

Completed

HepaSphere™ Microspheres Prospective Registry (mCRC)

Metastatic Colorectal Cancer

France, Greece
Merit Medical Systems, Inc.

Completed

The Merit WRAPSODY™ Endovascular Stent Graft

Venous Stenosis | Venous Occlusion

United Kingdom, Greece
Merit Medical Systems, Inc.

Completed

HeRO Vascular Access Device Post Market Procedural Survey Protocol (PPS)

End Stage Renal Disease
Merit Medical Systems, Inc.

Recruiting

US Post-Market Surveillance Study of the Surfacer System

Venous Disease

United States
Merit Medical Systems, Inc.

Active, not recruiting

The Merit WRAPSODY AV Access Efficacy Study (WAVE) (WAVE)

Venous Stenosis | Venous Occlusion

United States, United Kingdom, Canada, Brazil
Merit Medical Systems, Inc.

Withdrawn

The Merit WRAPSODY™ Endovascular Stent Graft for Treatment of Iliac Artery Occlusive Disease

Peripheral Arterial Disease | Iliac Artery Occlusion | Iliac Artery Disease | Stenosis of Artery
Merit Medical Systems, Inc.

Completed

Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter (MCENPS)

Pain; Dialysis Catheter

United States
Merit Medical Systems, Inc.

Recruiting

GAE Using Embosphere Microspheres vs Corticosteroid Injections for Treatment of Symptomatic Knee OA (MOTION)

Knee Osteoarthritis

Canada, United States, Brazil, United Kingdom
Merit Medical Systems, Inc.

Recruiting

EmboCube Gelatin Embolization to Control Bleeding or Hemorrhaging

Hemorrhage | Bleeding Hemorrhage

France, Australia
Merit Medical Systems, Inc.

Recruiting

Merit WRAPSODY™ Endoprosthesis for Treatment of Stenosis or Occlusion (WRAP)

Venous Stenosis | Venous Occlusion

Israel, Netherlands, Australia, United Kingdom, Brazil, Germany, New Zealand, Portugal, Greece
Merit Medical Systems, Inc.

Terminated

HepaSphere/Quadrasphere Microspheres for Delivery of Doxorubicin for the Treatment of Hepatocellular Cancer (HiQuality)

Hepatocellular Carcinoma

United States, France, Belgium, Greece, Italy
Merit Medical Systems, Inc.

Terminated

Prostate Artery Embolization With Embosphere Microspheres Compared to TURP for Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia

United States
Merit E. Cudkowicz, MD
Biohaven Pharmaceuticals, Inc.

Completed

HEALEY ALS Platform Trial - Regimen B Verdiperstat

Amyotrophic Lateral Sclerosis

United States
Jazz Pharmaceuticals
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer (SPRAY III)

Pain | Advanced Cancer

United States, Germany, United Kingdom, Mexico, Poland, Romania, Bulgaria, Czechia, Hungary, Puerto Rico
RVL Pharmaceuticals, Inc.
Osmotica Pharmaceutical US LLC

Completed

A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS (OS440-3004)

Multiple Sclerosis | Spasticity, Muscle

Serbia, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Moldova, Republic of, Poland
RVL Pharmaceuticals, Inc.
Osmotica Pharmaceutical US LLC

Completed

Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis

Multiple Sclerosis | Spasticity

United States, Russian Federation, Ukraine
Tetraphase Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections (IGNITE1)

Complicated Intra-abdominal Infections

United States, France, Ukraine, Argentina, Bulgaria, Romania, South Africa, Germany, Estonia, Russian Federation, Lithuania, Czechia, Latvia
Tetraphase Pharmaceuticals, Inc.

Completed

Study to Compare TP-434 and Ertapenem in Community-acquired Complicated Intra-abdominal Infections

Complicated Intra-abdominal Infection

United States, Latvia, Lithuania, Romania, India, Bulgaria
Tetraphase Pharmaceuticals, Inc.

Completed

Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections (IGNITE4)

Complicated Appendicitis | Complicated Intra-abdominal Infections

Ukraine, United States, Bulgaria, Romania, Estonia, Russian Federation, Lithuania, Hungary, Latvia, Georgia, Czechia
Tetraphase Pharmaceuticals, Inc.

Completed

A Thorough QT/QTc Study to Evaluate the Effects of an Intravenous Infusion of Eravacycline (TP-434) on Cardiac Repolarization

Normal Healthy Subjects
Merit Medical Systems, Inc.
CryoLife, Inc.

Completed

Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study

Renal Failure Chronic Requiring Hemodialysis

United States
Merit Medical Systems, Inc.
CryoLife, Inc.

Withdrawn

Data Collection Registry of the HeRO Graft for End Stage Renal Disease Patients Receiving Hemodialysis

End Stage Renal Failure on Dialysis

United States
Merit Medical Systems, Inc.
DFINE Inc.

Terminated

Evaluation of t-RFA and RF-TVA Prior to/Following Radiation Therapy to Treat Painful Metastatic Vertebral Body Tumor(s) (STARRT)

Metastatic Lesions in Vertebral Bodies

United States
Merit Medical Systems, Inc.
DFINE Inc.

Terminated

The STAR™ Tumor Ablation Registry

Metastatic Lesions in Vertebral Bodies

United States
Merit Medical Systems, Inc.
CryoLife, Inc.

Completed

HeRO Graft Compared to Permanent Catheters for End Stage Renal Disease (ESRD) Patients Receiving Hemodialysis

End Stage Renal Disease (ESRD)

United States
DFINE Inc.

Withdrawn

Evaluation of Vertebral Compression Fracture Fixation With RF Kyphoplasty in Patients With Multiple Myeloma (MM)

Multiple Myeloma | Compression Fracture of Vertebral Column
DFINE Inc.

Withdrawn

The PRIORi-T Trial--Prospective Randomized Investigation of Radiofrequency Targeted Vertebral Augmentation (PRIORi-T)

Painful Osteoporotic Vertebral Compression Fractures (VCF)

United States
DFINE Inc.

Completed

The STAR Prospective Clinical Series (PCS)

Metastasis to Vertebral Column

United States
DFINE Inc.

Terminated

Evaluating Clinical Outcomes of Targeted Radiofrequency Ablation and Kyphoplasty (Also Known as Vertebral Augmentation) to Treat Painful Metastatic Vertebral Body Tumors (EU-STAR)

Metastatic Lesions in Vertebral Bodies

Germany, Italy, France
RVL Pharmaceuticals, Inc.
Osmotica Pharmaceutical US LLC

Completed

One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity

Multiple Sclerosis | Spasticity

United States, Russian Federation, Ukraine
Tetraphase Pharmaceuticals, Inc.

Completed

A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy Subjects

Impaired Hepatic Function

United States
Tetraphase Pharmaceuticals, Inc.

Completed

A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With End Stage Renal Disease and Healthy Subjects

End Stage Renal Disease
Jazz Pharmaceuticals
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

Sativex® for Relieving Persistent Pain in Participants With Advanced Cancer

Pain | Advanced Cancer

United States, United Kingdom, Bulgaria, Belgium, Poland, Hungary, Romania, Czechia, Puerto Rico, Lithuania, Germany, Latvia
Jazz Pharmaceuticals
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced Cancer

Pain | Advanced Cancer

Israel, Italy, Taiwan, United Kingdom, Bulgaria, Hungary, India, Australia, Lithuania, Poland, Spain, Romania, Germany
Jazz Pharmaceuticals
Otsuka Pharmaceutical Development & Commercialization, Inc.

Completed

Long Term Safety of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related Pain

Pain | Advanced Cancer

Italy, United States, Taiwan, United Kingdom, Czechia, Bulgaria, Belgium, Latvia, Mexico, Lithuania, Poland, Romania, Hungary, Spain, Israel, Germany, Puerto Rico, Australia

Clinical Trials Sponsored by Verity Pharmaceuticals Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jordan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations